Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Clinical Lymphoma, Myeloma & Leukemia|August 11, 2021
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in SpainJosep-Maria Ribera, Mireia Morgades, Rosa Coll, et al.
Leukemia & Lymphoma|August 20, 2013
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic SyndromesBlanca Xicoy, María-José Jiménez, Olga García, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 28, 2020
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal ChemotherapyJosep-Maria Ribera, Olga García, Eduardo Cerello Chapchap, et al.
Leukemia Research|June 17, 2021
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)Eulàlia Genescà, Mireia Morgades, Celia González-Gil, et al.
Hemasphere|May 27, 2025
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trialsCelia González-Gil, Thaysa Lopes, Mireia Morgades, et al.
Blood|March 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemiaAïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti, et al.
Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.
Hematological Oncology|August 18, 2021
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trialsJosep-Maria Ribera, Mireia Morgades, Eulàlia Genescà, et al.
Experimental Hematology & Oncology|September 1, 2020
Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luis Piñana, Rodrigo Martino, Irene García-García, et al.
Scientific Reports|July 29, 2022
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNARicardo Sánchez, Sara Dorado, Yanira Ruíz-Heredia, et al.
Pageof 20